newsfilter
← Latest News
GlobeNewswire·

Salarius Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement

HOUSTON, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) (Salarius or the Company) announces that on September 4, 2025 the Company received notification from The Nasdaq Stock Market LLC